Comparative trial of efficacy and safety of cardosten, valsartan and their combination in patients with chronic heart failure

Trial Profile

Comparative trial of efficacy and safety of cardosten, valsartan and their combination in patients with chronic heart failure

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Sep 2011

At a glance

  • Drugs Angiotensin II receptor antibody; Valsartan
  • Indications Chronic heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Sep 2011 New trial record
    • 31 Aug 2011 Results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top